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a b s t r a c t
The synthesis of novel 2H-benzimidazole 1,3-dioxides on the basis of o-benzoquinone dioximes inter-
action with ketones in the presence of acids is described. Nitration of these compounds by nitric acid in
acetic acid yields the 5-nitro derivatives of 2H-benzimidazole 1,3-dioxide.
© 2017 Elsevier Ltd. All rights reserved.
1. Introduction
2H-Benzimidazole 1,3-dioxides exhibit high biological activity
and can be used as drugs against parasites Tripanosoma cruzi and
Leishmania spp.1 Approximately 30 million people are infected by
these parasites, and more than 400 million are constantly under
threat of infection according to the World Health Organization.2
Recently, it was reported that 2H-benzimidazole 1,3-dioxides are
inhibitors of separase - cysteine protease has playing an important
role in cell division.3 An appropriate patent has been published.4
The most potent inhibitor according to the authors is 2,2-
dimethyl-5-nitro-2H-benzimidazole 1,3-dioxide, that was ﬁrst
synthesized and described by us.5 It was named Sepin-1. It was
found that Sepin-1 inhibits the growth of malignant tumors by
inhibiting separase in cancer cells.6 The introduction of
substituents other than methyl in the second position of the
benzimidazole cycle, according to these authors, could increase the
inhibitory activity of 2H-benzimidazole 1,3-dioxides against
separase.
The search for biologically active compounds in the series of 2H-
benzimidazole 1,3-dioxides as drugs, both against Trypanosoma
cruzi and as separase inhibitor, involves the synthesis and biological
testing of new compounds. Fig. 1 shows the possible locations of
Sepin-1 molecule modiﬁcation.
In this paper, we have considered signiﬁcant changes in the
structure of Sepin-1:
Modiﬁcation 1 - the introduction of a nitro- and other groups in
various positions of the benzene ring.
Modiﬁcation 2 - introduction of various substituents other than
methyl in the 2-position.
Modiﬁcation 3 - removal one oxygen atom to afford mono-
oxides of 2H-benzimidazole.
There are two methods of synthesis of 2H-benzimidazole 1,3-
dioxides (Scheme 1): a) the reaction of benzofuroxans with sec-
ondary nitroalkane in the presence of bases,7 b) the condensation
of benzofuroxans with alcohols in the presence of acids.8 Unfor-
tunately, both methods have their limitations and provide the
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